ProKidney ($PROK) Insider Trading & Smart Money Activity

ProKidney Corp. · Biotechnology · Latest filing Jun 12, 2026

ProKidney Corp. ($PROK) has 4 insider trades on file. Insiders filed 4 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
0
13F moves on file
0
Analyst ratings on file
0

PROK insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 0 0 / 0 0 / 0
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All PROK insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Todd GirolamoChief Legal Officer Sell (Conversion) 163.86K sh +11.0%-1.8% —
Insider Todd GirolamoChief Legal Officer Sell (Conversion) 163.86K sh +11.0%-1.8% —
Insider Todd GirolamoChief Legal Officer Buy (Conversion) 163.86K sh +11.0%-1.8% Read
Insider Todd GirolamoChief Legal Officer Buy (Conversion) 163.86K sh +11.0%-1.8% Read

1W / 1M / 6M = how PROK moved from the trade or filing date.

Insider trading in PROK: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Todd Girolamo Chief Legal Officer 4 — Jun 12, 2026

Frequently asked questions

What is the latest insider trade in PROK?

Todd Girolamo, Chief Legal Officer filed a sell (conversion) of 163.86K sh on Jun 12, 2026.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text